4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-19-060100
EVP and CFO sold 36,000 shares at an average $49.66 ($1,787,853)
- EVP and CFO acquired 36,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ridloff Elena EVP and CFO | 2019-12-09 | Option exercise | +36,000 | $15.81 | $569,160 | 36,000 | D |
| Ridloff Elena EVP and CFO | 2019-12-09 | Sale | −11,020 | $50.60 | $557,557 | 24,980 | D |
| Ridloff Elena EVP and CFO | 2019-12-09 | Sale | −5,502 | $49.81 | $274,044 | 19,478 | D |
| Ridloff Elena EVP and CFO | 2019-12-09 | Sale | −19,478 | $49.09 | $956,253 | 0 | D |
| Derivatives | |||||||
| Ridloff Elena EVP and CFO | 2019-12-09 | Option exercise · Stock Option (Right to Buy) | −36,000 | 64,000 | D | ||
| Open-market sales · 36,000 sh · avg $49.66 · $1,787,853 | |||||||
Loading xslF345X03/doc4.xml…